1. 1202 Discussing and prescribing expensive unfunded anticancer drugs in Australia. (September 2015) Authors: Karikios, D.; Mileshkin, L.; Martin, A.; Ferraro, D.; Stockler, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1205 Is it all about price? Why anticancer drugs do not get recommended for government subsidy in Australia. (September 2015) Authors: Karikios, D.; Chim, L.; Martin, A.; Nagrial, A.; Salkeld, G.; Howard, K.; Stockler, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1535 Estimating scenarios for survival time in patients with HER2 positive, metastatic breast cancer starting HER2 targeted therapies. (September 2015) Authors: Vasista, A.; Stockler, M.; West, T.; Wilcken, N.; Kiely, B. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The effect of pulmonary function testing on bleomycin dosing in germ cell tumours. Issue 8 (August 2016) Authors: Roncolato, F. T.; Chatfield, M.; Houghton, B.; Toner, G.; Stockler, M.; Thomson, D.; Friedlander, M.; Gurney, H.; Rosenthal, M.; Grimison,, P. Journal: Internal medicine journal Issue: Volume 46:Issue 8(2016) Page Start: 893 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗